|Articles|July 1, 1998

New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
Volume 4
Issue 7 Suppl

How Far Have We Come in Treating Congestive Heart Failure?

Author(s)Bertram Pitt, MD

Download PDF: How Far Have We Come in Treating Congestive Heart Failure?

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Introduction: Current Concepts in Hypertension Management and A Look Toward the Future

over 27 years ago

Article

The Sixth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure

over 27 years ago

Article

Gene Polymorphism Influences Response to Angiotensin Blockade

over 27 years ago

Article

New Drug Class Offers Benefits in Heart Failure

over 27 years ago

Article

Comparative Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocking Agents on Left Ventricular Volumes in Elderly Patients with Heart Failure

over 27 years ago

Article

Phase I Results of the Randomized Evaluation of Left Ventricular Dysfunction (RESOLVD) Trial

over 27 years ago

Article

European Society of Cardiology: Angiotensin II Antagonists: Why is There So Much Excitement?

over 27 years ago

Article

What are the Pharmacological Differences Between Angiotensin II Antagonists

over 27 years ago

Article

Clinical Implications of Differences Between Angiotensin II Antagonists

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

How Far Have We Come in Treating Congestive Heart Failure?

Articles in this issue

Newsletter

Related Content

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

5 Ongoing Phase 3 Trials in Hematologic Malignancies

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

ACE Inhibitors Linked to Reduced Mortality in Patients with Idiopathic Pulmonary Fibrosis

Clinical Trial Data Signal a New Era for Atopic Dermatitis, Melanoma, and Psoriasis